Activation of Bcl-2 promoter-directed gene expression by the human immunodeficiency virus type-1 Tat protein

Virology

Volumn 257, Issue 2, 1999, Pages 502-510

  Wang, Zhongde ^a   Morris, Gilbert F ^a   Reed, John C ^b   Kelly, Gloria D ^c   Morris, Cindy B ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BURNHAM INSTITUTE   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; PROTEIN BCL 2; TRANSACTIVATOR PROTEIN;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL SURVIVAL; GENE ACTIVATION; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LEUKEMIA CELL LINE; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSACTIVATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0033541959     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9688     Document Type: Article

References (60)

1. Ameisen J.C. Programmed cell death and AIDS: from hypothesis to experiment. Immunol. Today. 13:1992;388-391.
2. Biswas D. K., Salas T. R., Wang F., Ahlers C. M., Dezube B. J., Pardee A. B. A Tat-induced auto-up-regulatory loop for superactivation of the human immunodeficiency virus type 1 promoter. J. Virol. 69:1995;7437-7444.
3. Buonaguro L., Buonaguro F. M., Giraldo G., Ensoli B. The human immunodeficiency virus type-1 Tat protein transactivates tumor necrosis factor b gene expression through TAR-like structure. J. Virol. 68:1994;2677-2682.
4. Chen G., Branton P. E., Yang E., Korsmeyer S. J., Shore G. C. Adenovirus E1B 19kDa death suppressor protein interacts with Bax but not Bad. J. Biol. Chem. 271:1996;24221-24225.
5. Chen H.-M., Boxer L. M. Pi 1 binding sites are negative regulators of bcl-2 expression in pre-B cells. Mol. Cell. Biol. 15:1995;3840-3847.
6. Chowdhury M., Taylor J. P., Chang C. F., Rappaport J., Khalili K. Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat. J. Virol. 66:1992;7355-7361.
7. Chowdhury M., Taylor J. P., Tada H., Rappaport J., Wong-Staal F., Amini S., Khalili K. Regulation of the human neurotrophic virus promoter JCV-T antigen and HIV-1 Tat protein. Oncogene. 15:1990;1737-1742.
8. Cullen B. R. HIV-1 auxiliary proteins: Making connection in a dying cell. Cell. 93:1998;685-692.
9. Cupp C., Taylor J. P., Khalili K., Amini S. Evidence for stimulation of the transforming growth factor β1 promoter by HIV-1 Tat in cells derived from CNS. Oncogene. 8:1993;2231-2236.
10. Debbas M., White E. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7:1993;546-554.
11. Di Luca D., Secchiero P., Bovenzi P. Reciprocal in vitro interactions between human herpes virus-6 and HIV-1 Tat. AIDS. 5:1991;1095-1098.
12. Emerman M., Malim M. H. HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology. Scienc. 280:1998;1880-1884.
13. Ensoli B., Barillari G., Salahuddin S. Z., Gallo R. C., Wong-Staal F. Tat protein of HIV-1 stimulates growth of AIDS-Kaposi's sarcoma-derived cells. Nature. 345:1990;84-86.
14. Ensoli B., Buonaguro L., Barillari G., Fiorelli V., Gendelman R., Morgan R. A., Wingfield P., Gallo R. C. Release, uptake and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67:1993;277-287.
15. Fauci A. S. Multifactorial nature of human immunodeficiency disease: Implications for therapy. Science. 262:1993;1011-1018.
16. Frampton J., Ramqvist T., Graf T. v-Myb of E26 leukemia virus up-regulates bcl-2 and suppresses apoptosis in myeloid cells. Genes Dev. 10:1996;2720-2731.
17. Geiger K. D., Gurushanthaiah D., Howes E. L., Lewandowski G. A., Reed J. C., Bloom F. E., Sarvetnick N. E. Cytokine-mediated survival from lethal herpes simplex virus infection role of programmed neuronal death. Proc. Natl. Acad. Sci. USA. 92:1995;3411-3415.
18. Gorman C. M., Moffat L. R., Howard B. H. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1982;1044-1051.
19. Harigai M., Miyashita T., Hanada M., Reed J. C. A cis-acting element in the BCL-2 gene controls expression through translational mechanisms. Oncogene. 12:1996;1369-1374.
20. Harlow E., Lane D. Antibodies: A Laboratory Manual. 1988;Cold Spring Harbor Laboratory, Cold Spring Harbor.
21. Heckman C., Mochon E., Arcinas M., Boxer L. M. The WT1 protein is a negative regulator of the normal bcl-2 allele in t(14;18) lymphomas. J. Biol. Chem. 272:1997;19609-19614.
22. Henderson S., Huen D., Rowe M., Dawson C., Johnson G., Rickinson A. Epstein-Barr virus-coded BHRFI protein, a viral homologue of bcl-2, protects human B-cells from programmed cell death. Proc. Natl. Acad. Sci. USA. 90:1993;8479-8485.
23. Henderson S., Rowe M., Gregory C., Croom-Carter D., Wang F., Longnecker R., Kieff E., Rickinson A. Induction of bcl-2 by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell. 65:1991;1107-1115.
24. Hewitt S. M., Hamada S., McDonnell T. J., Rauscher I., Saunders G. F. Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1. Cancer Res. 55:1996;5386-5389.
25. Hewitt S. M., Hamada S., Monarres A., Kottical L. V., Saunders G. F., McDonnell T. J. Transcriptional activation of the bcl-2 apoptosis suppressor gene by the paired box transcription factor PAX8. Anticancer Res. 17:1997;3211-3215.
26. Huang R.-P., Fan Y., Peng A., Zeng Z.-L., Reed J. C., Adamson E. D., Boynton A. L. Suppression of human fibrosarcoma cell growth by transcription factor, Egr-1, involve down-regulation of Bcl-2. Int. J. Cancer. 77:1998;880-886.
27. Jeang K. T. Tat, Tat-associated kinase, and transcription. J. Biomed. Sci. 5:1998;24-27.
28. Jones K. Taking a new TAK on Tat transactivation. Genes Dev. 11:1997;2593-2599.
29. Kim Y. S., Risser R. TAR-independent transactivation of the marine cytomegalovirus immediate-early promoter by the Tat protein. J. Virol. 67:1993;239-248.
30. McCloskey T. M., Ott M., Tribble E., Khan S. A., Teichberg S., Paul M. O., Pahwa S., Verdin E., Chirmule N. Dual role of HIV Tat in regulation of apoptosis in T cells. J. Immunol. 158:1997;1014-1019.
31. Miller L. K. Baculovirus interaction with host apoptotic pathways. J. Cell. Physiol. 173:1997;178-182.
32. Miyashita T., Harigai M., Hanada M., Reed J. C. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res. 54:1994;3131-3135.
33. Morris C. B., Gendelman R., Marrogi A. J., Lu M., Lockyer J. M., Alperin-Lea W., Ensoli B. Immunohistochemical detection of Bcl-2 in AIDS-associated and classical Kaposi's sarcoma. Am. J. Pathol. 148:1996;1055-1063.
34. Morris G. F., Mathews M. B. The adenovirus E1A transforming protein activates the proliferating cell nuclear antigen promoter via an activating transcription factor site. J. Virol. 65:1991;6397-6406.
35. Nabell L. M., Rafa R. H., Sayeski P. P., Paterson A. J., Kudlow J. E. Human immunodeficiency virus 1 Tat stimulates transcription of the transforming growth factor alpha gene in an epidermal growth factor-dependent manner. Cell Growth Diff. 5:1994;87-93.
36. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
37. Nardelli B., Gonzalez C. J., Schechter M., Valentine F. T. CD4+ blood lymphocytes are rapidly killed in vitro by contact with autologous human immunodeficiency virus-infected cells. Proc. Natl. Acad. Sci. USA. 92:1995;7312-7316.
38. Okan I., Wang Y., Chen F., Hu L. F., Imreh S., Klein G., Wiman K. G. The EBV-encoded LMP1 protein inhibits p53-triggered apoptosis but not growth arrest. Oncogene. 11:1995;1027-1031.
39. Puri R. K., Aggarwal B. B. HIV-1 tat gene up-regulates IL-4 receptors on a human B-lymphoblastoid cell line. Cancer Res. 52:1992;3787-3790.
40. Rice A. P., Carlotti F. Mutational analysis of the conserved cysteine-rich regions of the human immunodeficiency virus type 1 Tat protein. J. Virol. 64:1990a;1864-1868.
41. Rice A. P., Carlotti F. Structural analysis of wild-type and mutant human immunodeficiency virus type 1 Tat protein. J. Virol. 64:1990b;6018-6026.
42. Sarid R., Sato T., Bohenzky R. A., Russo J. J., Chang Y. Kaposi's sarcoma-associated herpes virus encodes a functional bcl-2 homologue. Nat. Med. 3:1997;293-298.
43. Sastry K. J., Marin M. C., Nehete P. N., McConnell K., El-Naggar A. K., McDonnell T. J. Expression of human immunodeficiency virus type 1 tat results in down-regulation of bcl-2 and induction of apoptosis in hematopoietic cells. Oncogene. 13:1996;487-493.
44. Scala G., Ruocco M. R., Ambrosino C., Mallardo M., Giordano V., Baldassarre F., Dragonetti E., Quinto I., Venuta S. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 Tat protein. J. Exp. Med. 179:1994;961-971.
45. Seto M., Jaeger U., Hockett R. D., Graninger W., Bennett S., Goldman P., Korsmeyer S. J. Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma. EMBO J. 7:1988;123-131.
46. Silin S. C., Sculley T. B. Burkitt's lymphoma cells are resistant to programmed cell death in the presence of the Epstein-Barr virus latent antigen EBNA-4. Int. J. Cancer. 60:1995;65-72.
47. Smith M. D., Ensor E. A., Coffin R. S., Boxer L. M. Bcl-2 transcription from the proximal P2 promoter is activated in neuronal cells by the Brn-3a POU family transcription factor. J. Biol. Chem. 273:1998;16715-16722.
48. Taylor D., Badiani P., Weston K. A dominant interfering Myb mutant causes apoptosis in T cells. Genes Dev. 10:1996;2732-2744.
49. Taylor J. P., Pomerantz R., Bagasra O., Chowdhury M., Rappaport J., Khalili K., Amini S. The TAR-independent transactivation by Tat in cells derived from the CNS: A novel mechanism of HIV-1 gene regulation. EMBO J. 11:1992;3395-3403.
50. Ursini M. V., Lettieri T., Braddock M., Martini G. Enhanced activity of human G6PD promoter transfected in HeLa cells producing high level of HIV Tat. Virology. 196:1993;338-343.
51. Wattre P., Bert V., Hober D. Apoptosis and human viral infections. Ann. Biol. Clin. 54:1996;189-197.
52. Westendorp M. D., Li-Weber M., Frank R. W., Krammer R. H. Human immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cells. J. Virol. 68:1994;4177-4185.
53. Wilson B. E., Mochon E., Boxer L. M. Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. Mol. Cell. Biol. 16:1996;5546-5556.
54. Wright S., Lu X., Peterlin B. M. Human immunodeficiency virus type 1 Tat directs transcription through attenuation sites within the mouse c-myc gene. J. Mol. Biol. 243:1994;568-573.
55. Yang E., Korsmeyer S. J. Molecular thanatopsis: A discourse on the BCL2 family and cell death. Blood. 88:1996;286-401.
56. Yang L., Morris G. F., Lockyer J. M., Wang Z., Morris C. B. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat. Virology. 235:1997;48-64.
57. Yankulov K., Bentley D. Transcriptional control: Tat cofactors and transcriptional elongation. Curr. Biol. 8:1998;R447-R449.
58. Young R. L., Korsmeyer S. J. A negative regulatory element in the bcl-2 5′-untranslated region inhibits expression from an upstream promoter. Mol. Cell. Biol. 13:1993;3686-3697.
59. Zauli G., Gibellini D., Caputo A., Bassini A., Negrini N., Monne M., Mazzoni M., Capitani S. The human immunodeficiency virus type-1 Tat protein upregulates bcl-2 gene expression in Jurkat T cell lines and primary peripheral blood mononuclear cells. Blood. 86:1995;3823-3834.
60. Zauli G., Gibellini D., Milani D., Mazzoni M., Borgatti P., La Placa M., Capitani S. Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis. Cancer Res. 5:1993;4481-4484.